Clinical trial · Observational
Visual Outcome After Transsphenoidal Surgery for Pituitary Macroadenoma
NCT03363126CI-TRIAL-00030693RetroADENcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Endoscopic endonasal transsphenoidal surgery is a procedure for the treatment of pituitary macroadenomas that cause visual impairment through optic chiasm compression. The aim of this retrospective study is to describe visual outcome after this procedure.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Optic Chiasm Disorder | — | UNRESOLVED | — |
| Pituitary Tumor | Pituitary Gland Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Endonasal transsphenoidal pituitary tumor removal | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Post-operative gain in visual acuity
- timeFrame
- six months
- description
- Difference between pre-operative and post-operative visual acuity, expressed in LogMAR
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Pituitary tumor causing optic chiasm compression (documented on MRI or CT-scan) * Visual impairment caused by chiasm compression * Treatment by transsphenoidal endonasal surgery * Treatment in the Rothschild Foundation (Paris) between 2009 and 2013 Exclusion Criteria: * Ophtalmologic condition other than optic chiasm compression
References
Publications (0)
Data not yet available
No reference posted for this study.